Myl2tm1(cre)Krc/Myl2+ Rxratm1Krc/Rxratm1Krc
involves: 129S4/SvJae * Black Swiss
|
no abnormal phenotype detected |
J:48085
|
Rxrapke/Rxrapke
C57BL/6J-Rxrapke
|
abnormal dendritic cell physiology |
J:103186
|
abnormal regulatory T cell physiology |
J:103186
|
abnormal T-helper 2 cell morphology |
J:103186
|
alopecia |
J:103186
|
cornea opacity |
J:103186
|
dermal cyst |
J:103186
|
diluted coat color |
J:103186
|
kyphosis |
J:103186
|
Rxratm1.1Krc/Rxratm1.1Krc
involves: 129S4/SvJae * Black Swiss
|
congestive heart failure |
J:48085
|
lethality throughout fetal growth and development, complete penetrance |
J:48085
|
Rxratm1.1Pcn/Rxratm1.1Pcn
involves: 129S2/SvPas * C57BL/6 * SJL
|
abnormal conotruncus septation |
J:146761
|
abnormal cornea stroma morphology |
J:146761
|
abnormal eyelid morphology |
J:146761
|
abnormal ocular fundus morphology |
J:146761
|
abnormal optic disk morphology |
J:146761
|
abnormal pharyngeal arch artery morphology |
J:146761
|
abnormal placenta labyrinth morphology |
J:146761
|
abnormal placenta morphology |
J:146761
|
absent Harderian gland |
J:146761
|
absent sclera |
J:146761
|
absent sublingual duct |
J:146761
|
decreased fetal size |
J:146761
|
decreased ventral retina size |
J:146761
|
lethality throughout fetal growth and development, incomplete penetrance |
J:146761
|
perinatal lethality, complete penetrance |
J:146761
|
persistent hyperplastic primary vitreous |
J:146761
|
ventral rotation of lens |
J:146761
|
ventricular myocardium compact layer hypoplasia |
J:146761
|
Rxratm1Ipc/Rxratm1Ipc
involves: 129S2/SvPas
|
abnormal epidermis stratum corneum morphology |
J:109090
|
abnormal keratinocyte morphology |
J:109090
|
abnormal skin condition |
J:109090
|
abnormal skin morphology |
J:109090
|
lethality throughout fetal growth and development, complete penetrance |
J:60351
|
ventricular hypoplasia |
J:60351
|
Rxratm1Ipc/Rxratm1Ipc Tg(Myh6-Rxra)41Pcn/0
involves: 129S2/SvPas
|
lethality throughout fetal growth and development, complete penetrance |
J:60351
|
ventricular hypoplasia |
J:60351
|
Rxratm1Ipc/Rxratm2Ipc
involves: 129S2/SvPas * C57BL/6
|
abnormal eye development |
J:146761
|
Rxratm1Krc/Rxra+ Tg(Pbsn-cre)4Prb/0
involves: 129S4/SvJae * C57BL/6 * DBA/2
|
abnormal prostate gland branching morphogenesis |
J:78553
|
increased prostate intraepithelial neoplasia incidence |
J:78553
|
prostate gland epithelial hyperplasia |
J:78553
|
Rxratm1Krc/Rxratm1Krc Lyz2tm1(cre)Ifo/Lyz2+
involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6
|
abnormal kidney morphology |
J:168799
|
abnormal macrophage activation involved in immune response |
J:168799
|
abnormal nephron morphology |
J:168799
|
abnormal peritoneal macrophage morphology |
J:168799
|
abnormal podocyte foot process morphology |
J:168799
|
abnormal renal glomerulus morphology |
J:168799
|
albuminuria |
J:168799
|
enlarged kidney |
J:168799
|
expanded mesangial matrix |
J:168799
|
fused podocyte foot processes |
J:168799
|
glomerulonephritis |
J:168799
|
impaired macrophage phagocytosis |
J:168799
|
increased anti-double stranded DNA antibody level |
J:168799
|
increased anti-nuclear antigen antibody level |
J:168799
|
increased anti-single stranded DNA antibody level |
J:168799
|
increased autoantibody level |
J:168799
|
increased circulating creatine level |
J:168799
|
increased IgG level |
J:168799
|
increased IgM level |
J:168799
|
increased kidney weight |
J:168799
|
increased mesangial cell number |
J:168799
|
increased renal glomerulus apoptosis |
J:168799
|
increased renal glomerulus basement membrane thickness |
J:168799
|
increased urine protein level |
J:168799
|
renal glomerulus hypertrophy |
J:168799
|
Rxratm1Krc/Rxratm1Krc Tg(Pbsn-cre)4Prb/0
involves: 129S4/SvJae * C57BL/6 * DBA/2
|
abnormal prostate gland branching morphogenesis |
J:78553
|
abnormal prostate gland physiology |
J:78553
|
increased prostate intraepithelial neoplasia incidence |
J:78553
|
Rxratm1Rev/Rxra+
involves: 129S4/SvJae * C57BL/6
|
abnormal atrioventricular valve morphology |
J:35363
|
abnormal heart development |
J:35363
|
abnormal heart ventricle morphology |
J:35363
|
abnormal interventricular septum morphology |
J:35363
|
abnormal mitral valve morphology |
J:35363
|
abnormal myocardial trabeculae morphology |
J:35363
|
abnormal myocardium compact layer morphology |
J:35363
|
abnormal myocardium layer morphology |
J:35363
|
abnormal tricuspid valve morphology |
J:35363
|
abnormal ventricle papillary muscle morphology |
J:35363
|
decreased heart left ventricle wall thickness |
J:35363
|
decreased heart right ventricle wall thickness |
J:35363
|
double outlet right ventricle |
J:35363
|
mitral valve stenosis |
J:35363
|
pulmonary artery stenosis |
J:35363
|
thin ventricular wall |
J:35363
|
Rxratm1Rev/Rxratm1Rev
involves: 129S4/SvJae * C57BL/6
|
abnormal atrioventricular cushion morphology |
J:35363
|
abnormal conotruncal ridge morphology |
J:35363
|
abnormal heart left atrium morphology |
J:65904
|
abnormal heart morphology |
J:65904
|
abnormal heart ventricle shape |
J:18047,
J:65904
|
abnormal mitral valve morphology |
J:35363
|
abnormal myocardial trabeculae morphology |
J:35363
|
abnormal myocardium compact layer morphology |
J:18047
|
abnormal myocardium layer morphology |
J:18047,
J:35363
|
abnormal pericardial cavity morphology |
J:18047
|
abnormal pericardium morphology |
J:18047
|
abnormal tricuspid valve morphology |
J:35363
|
abnormal truncus arteriosus septation |
J:18047
|
abnormal ventricle papillary muscle morphology |
J:35363
|
aortopulmonary window |
J:35363
|
atrioventricular block |
J:65904
|
complete atrioventricular septal defect |
J:35363
|
congestive heart failure |
J:18047,
J:65904
|
decreased cardiac output |
J:65904
|
decreased heart rate |
J:65904
|
decreased hepatocyte proliferation |
J:18047
|
decreased ventricle muscle contractility |
J:65904
|
delayed hepatic development |
J:18047
|
dilated heart right atrium |
J:18047
|
dilated heart right ventricle |
J:18047
|
double outlet right ventricle |
J:35363
|
failure of atrioventricular cushion closure |
J:35363
|
heart block |
J:65904
|
lethality throughout fetal growth and development, complete penetrance |
J:18047
|
mitral valve atresia |
J:18047
|
muscular ventricular septal defect |
J:18047,
J:35363,
J:65904
|
persistent truncus arteriosus |
J:35363
|
skin edema |
J:18047
|
small liver |
J:18047
|
thin ventricular wall |
J:18047,
J:35363
|
trabecula carnea hypoplasia |
J:18047
|
translucent skin |
J:18047
|
ventricular hypoplasia |
J:18047
|
ventricular myocardium compact layer hypoplasia |
J:35363
|
Rxratm2Ipc/Rxra+
involves: 129
|
abnormal postnatal growth/weight/body size |
J:20550
|
Rxratm2Ipc/Rxratm2Ipc
involves: 129
|
abnormal cardiovascular system morphology |
J:20550
|
abnormal cricoid cartilage morphology |
J:42773
|
abnormal extraembryonic tissue morphology |
J:44230
|
abnormal eye morphology |
J:20550
|
prenatal lethality |
J:20550
|
Rxratm2Ipc/Rxratm4.1Ipc
involves: 129
|
abnormal eye development |
J:67149
|
abnormal vasculogenesis |
J:67149
|
edema |
J:67149
|
lethality throughout fetal growth and development, complete penetrance |
J:67149
|
pallor |
J:67149
|
Rxratm2Ipc/Rxratm4Ipc Tg(KRT14-cre)1Ipc/0
involves: 129S2/SvPas * C57BL/6 * SJL
|
abnormal hair cycle anagen phase |
J:67149
|
abnormal hair cycle telogen phase |
J:67149
|
abnormal hair follicle melanin granule distribution |
J:67149
|
abnormal hair follicle morphology |
J:67149
|
abnormal hair growth |
J:67149
|
abnormal Langerhans cell morphology |
J:67149
|
abnormal melanosome morphology |
J:67149
|
abnormal piliary canal morphology |
J:67149
|
abnormal skin morphology |
J:67149
|
alopecia |
J:67149
|
delayed hair appearance |
J:67149
|
dermal cyst |
J:67149
|
dilated piliary canal |
J:67149
|
diluted coat color |
J:67149
|
disorganized outer root sheath cells |
J:67149
|
distorted hair follicle pattern |
J:67149
|
hair follicle degeneration |
J:67149
|
hyperkeratosis |
J:67149
|
increased keratinocyte proliferation |
J:67149
|
scaly skin |
J:67149
|
skin inflammation |
J:67149
|
skin lesions |
J:67149
|
thick dermal layer |
J:67149
|
thick epidermis suprabasal layer |
J:67149
|
thin hypodermis |
J:67149
|
Rxratm3Ipc/Rxratm3Ipc
involves: 129 * C57BL/6
|
abnormal axial skeleton morphology |
J:69853
|
abnormal cardiovascular system morphology |
J:69853
|
abnormal digit morphology |
J:69853
|
abnormal eye morphology |
J:69853
|
abnormal postnatal growth/weight/body size |
J:69853
|
abnormal skeleton development |
J:69853
|
normal
behavior/neurological phenotype |
J:69853
|
postnatal lethality, incomplete penetrance |
J:69853
|
Rxratm4.1Ipc/Rxratm4.1Ipc
involves: 129S2/SvPas
|
abnormal eye development |
J:67149
|
abnormal vasculogenesis |
J:67149
|
edema |
J:67149
|
lethality throughout fetal growth and development, complete penetrance |
J:67149
|
pallor |
J:67149
|
Rxratm4Ipc/Rxratm4Ipc Tg(KRT14-cre)1Ipc/0
involves: 129S2/SvPas * C57BL/6 * SJL
|
abnormal epidermis stratum corneum morphology |
J:109090
|
abnormal keratinocyte morphology |
J:109090
|
shiny skin |
J:109090
|
Rxratm4Ipc/Rxratm4Ipc Tg(Tyrp1-cre)1Ipc/0
involves: 129S2/SvPas
|
abnormal cone electrophysiology |
J:88451
|
abnormal photoreceptor outer segment morphology |
J:88451
|
abnormal retina outer nuclear layer morphology |
J:88451
|
abnormal retina pigment epithelium morphology |
J:88451
|
abnormal retina pigmentation |
J:88451
|
abnormal rod electrophysiology |
J:88451
|
decreased retina photoreceptor cell number |
J:88451
|
delayed dark adaptation |
J:88451
|
disorganized photoreceptor outer segment |
J:88451
|
retina pigment epithelium atrophy |
J:88451
|
short photoreceptor outer segment |
J:88451
|
Tg(Myh6-Rxra)41Pcn/0
Not Specified
|
abnormal cardiac thrombosis |
J:60351
|
abnormal M line morphology |
J:60351
|
abnormal myocardial fiber morphology |
J:60351
|
abnormal respiratory electron transport chain |
J:60351
|
abnormal sarcomere morphology |
J:60351
|
abnormal Z line morphology |
J:60351
|
dilated cardiomyopathy |
J:60351
|
enlarged heart |
J:60351
|
myocardial fiber degeneration |
J:60351
|
pleural effusion |
J:60351
|
premature death |
J:60351
|